Aprea Therapeutics
APRE
#9651
Rank
A$27.36 M
Marketcap
$5.03
Share price
-2.99%
Change (1 day)
-18.05%
Change (1 year)

Aprea Therapeutics (APRE) Fails to deliver data

Key failure to deliver metrics for Aprea Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Aprea Therapeutics (APRE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Aprea Therapeutics (APRE) - since 2023

Volume in USD (price x number of shares), data since 2023

Aprea Therapeutics (APRE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$1.18 M223.09%
2023A$0.36 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$3.58 MA$4.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.83 MA$13.29 M๐Ÿ‡บ๐Ÿ‡ธ USA